Cleared Traditional

LILY Extension Tube and Needleless Connector (K222780) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222780 · Lily Medical Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2023
Decision
421d
Days
Class 2
Risk

K222780 is an FDA 510(k) clearance for the LILY Extension Tube and Needleless Connector. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Lily Medical Corporation (Miaoli County, CN). The FDA issued a Cleared decision on November 9, 2023 after a review of 421 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Lily Medical Corporation devices

Submission Details

510(k) Number K222780 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2022
Decision Date November 09, 2023
Days to Decision 421 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
292d slower than avg
Panel avg: 129d · This submission: 421d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Benq Medical Technology Corporation
Steven Shen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 238
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K222780.
Insignis™ Syringe Infusion System
K232328 · Innovative Health Sciences, LLC · Mar 2024
ResQ Administration Set
K231707 · Q For Plastic Industries · Jan 2024
Extension Set
K230528 · Medcaptain Life Science Co., Ltd. · Dec 2023
ProSeal™ Closed System Administration Set
K230343 · Epic Medical Pte. , Ltd. · Nov 2023
BD Alaris™ Pump Infusion Sets
K221327 · Care Fusion · Jul 2023
Surflo Winged Infusion Set
K221411 · Terumo Medical Products Hangzhou Co., Ltd. · Jun 2023